Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nhut Le

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Scientific Data|May 20, 2026
3DAeroRelief: The first 3D Benchmark UAV Dataset for Post-Disaster AssessmentNhut Le, Ehsan Karimi, Maryam Rahnemoonfar
Clinical Medicine. Therapeutics|November 19, 2009
Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist MaravirocOlga Latinovic, Janaki Kuruppu, Charles Davis, et al.
Organic & Biomolecular Chemistry|April 29, 2005
Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120Jingsong Wang, Nhut Le, Alonso Heredia, et al.
AIDS (London, England)|February 16, 2007
HIV-1 natural viral suppressors: control of viral replication in the absence of therapyMohammad M Sajadi, Alonso Heredia, Nhut Le, et al.
Antiviral Research|June 9, 2009
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonistsOlga Latinovic, Alonso Heredia, Robert C Gallo, et al.
AIDS (London, England)|May 4, 2005
In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implicationsAlonso Heredia, Charles Davis, Anthony Amoroso, et al.
Bioconjugate Chemistry|July 22, 2004
Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniproteinHengguang Li, Haijing Song, Alonso Heredia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1Alonso Heredia, Olga Latinovic, Robert C Gallo, et al.
AIDS (London, England)|April 21, 2011
Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionOlga Latinovic, Nhut Le, Marvin Reitz, et al.
Digital Health|June 8, 2026
TNmindtest: Development and evaluation of a web-based cognitive screening tool for mild cognitive impairment in Vietnamese adultsQuynh Phuong Vo, Khang Vinh Nguyen, Duc Nhut Le, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Scientific Data|May 20, 2026
3DAeroRelief: The first 3D Benchmark UAV Dataset for Post-Disaster AssessmentNhut Le, Ehsan Karimi, Maryam Rahnemoonfar
Clinical Medicine. Therapeutics|November 19, 2009
Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist MaravirocOlga Latinovic, Janaki Kuruppu, Charles Davis, et al.
Organic & Biomolecular Chemistry|April 29, 2005
Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120Jingsong Wang, Nhut Le, Alonso Heredia, et al.
AIDS (London, England)|February 16, 2007
HIV-1 natural viral suppressors: control of viral replication in the absence of therapyMohammad M Sajadi, Alonso Heredia, Nhut Le, et al.
Antiviral Research|June 9, 2009
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonistsOlga Latinovic, Alonso Heredia, Robert C Gallo, et al.
AIDS (London, England)|May 4, 2005
In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implicationsAlonso Heredia, Charles Davis, Anthony Amoroso, et al.
Bioconjugate Chemistry|July 22, 2004
Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniproteinHengguang Li, Haijing Song, Alonso Heredia, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1Alonso Heredia, Olga Latinovic, Robert C Gallo, et al.
AIDS (London, England)|April 21, 2011
Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionOlga Latinovic, Nhut Le, Marvin Reitz, et al.
Digital Health|June 8, 2026
TNmindtest: Development and evaluation of a web-based cognitive screening tool for mild cognitive impairment in Vietnamese adultsQuynh Phuong Vo, Khang Vinh Nguyen, Duc Nhut Le, et al.
Pageof 2